Total planned funding: $206,937,289
Allocations
Countries/Regions
Ukraine | $206,937,289 |
Organizational Types
NGO | $52,518,709 |
Unknown | $47,203,694 |
Private Contractor | $36,967,394 |
Own Agency | $28,429,434 |
Multi-lateral Agency | $15,801,607 |
University | $10,460,000 |
Implementing Agency | $7,897,040 |
Other USG Agency | $6,059,411 |
Host Country Government Agency | $1,600,000 |
Program Areas
Governance and Systems | $89,962,054 |
Treatment | $36,049,607 |
Testing | $22,341,748 |
Prevention | $22,183,195 |
Management and Operations | $20,664,538 |
Care | $15,323,447 |
Budget Codes
OHSS: Health Systems Strengthening | $50,569,986 |
HTXS: Treatment: Adult Treatment | $23,511,436 |
HVSI: Strategic Information | $23,387,030 |
HVCT: Testing: HIV Testing and Counseling | $22,341,748 |
HVMS: Management and Operations | $20,664,538 |
HLAB: Laboratory Infrastructure | $16,005,038 |
HTXD: Treatment: ARV Drugs | $12,538,171 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $11,428,118 |
HVTB: Care: TB/HIV | $8,645,349 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,217,938 |
HBHC: Care: Adult Care and Support | $4,573,287 |
HMBL: Biomedical Prevention: Blood Safety | $3,465,039 |
HKID: Care: Orphans and Vulnerable Children | $2,104,811 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $72,100 |
PDTX: Treatment: Pediatric Treatment | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
Top Partner Programs
Not Available:
$44,138,410
Countries/Regions
USG Aggregated Agencies:
$22,862,698
Countries/Regions
Chemonics International:
$20,692,383
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions